Meeting
2022 ASCO Genitourinary Cancers Symposium
Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization.
Authors
Wesley Yip
Memorial Sloan Kettering Cancer Center, New York, NY
Wesley Yip , Kwanghee Kim , Fengshen Kuo , Andrew Thomas Lenis , Jie-Fu Chen , Wenhuo Hu , Timothy Nguyen Clinton , Carissa Ellen Chu , Nima Almassi , Andrew Tracey , Peter Reisz , Jasmine Thomas , Lucas Nogueira , Yoichi Fujii , Gopa Iyer , Hikmat A. Al-Ahmadie , A. Ari Hakimi , Taha Merghoub , David B. Solit , Jonathan Coleman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 564)
DOI
10.1200/JCO.2022.40.6_suppl.564
Abstract #
564
Poster Bd #
K6
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
FIDES-02, a phase Ib/II study of derazantinib (DZB) as monotherapy and combination therapy with atezolizumab (A) in patients with surgically unresectable or metastaticurothelial cancer (UC) and FGFR genetic aberrations.
First Author: Arvind Chaudhry
First Author: Gabriel G. Malouf
Poster
2024 ASCO Annual Meeting
Dissecting the significance of ACP1 gene alterations in prostate cancer (PCa).
First Author: Nour Abdallah
Poster
2024 ASCO Annual Meeting
Longitudinal circulating tumor DNA monitoring in predicting response to short-course neoadjuvant radiotherapy in locally advanced rectal cancer: Data from a phase III clinical trial (UNION).
First Author: Zhenyu Lin